Rapid Micro Biosystems (RPID) Equity Average (2020 - 2026)

Rapid Micro Biosystems has disclosed Equity Average across 7 years of filings, most recently posting $26.8 million for Q1 2026.

• Equity Average for Q1 2026 came in at $26.8 million, down 61.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.8 million (down 61.94% YoY), and the FY2025 annual result was $54.3 million, down 43.85% from the prior year.
• Equity Average came in at $26.8 million for Q1 2026 at Rapid Micro Biosystems, down from $38.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $214.0 million in Q1 2022 to a low of $26.8 million in Q1 2026.
• The 5-year median for Equity Average is $112.0 million (2024), against an average of $115.4 million.
• Across the five-year window, Equity Average surged 432.6% in 2022 and tumbled 61.94% in 2026, its largest moves.
• Rapid Micro Biosystems' Equity Average stood at $171.6 million in 2022, then decreased by 28.38% to $122.9 million in 2023, then plunged by 35.01% to $79.9 million in 2024, then tumbled by 51.46% to $38.8 million in 2025, then plunged by 30.87% to $26.8 million in 2026.
• The last three Equity Average figures came in at $26.8 million (Q1 2026), $38.8 million (Q4 2025), and $49.4 million (Q3 2025), per Business Quant data.